Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
The most recent 10-K adequately displays the directors holdings, fiscal year end June 2019. There has been no dumping of shares, since initial award by any party. I'm amazed by the time you waste fabricating something so easily disproved.
If you would like to link to any SEC filing, please do so directly to Edgar.
E.g., 10-k I referenced, which demonstrates maintained holdings by all directors.
https://www.sec.gov/Archives/edgar/data/1382943/000109181819000239/0001091818-19-000239-index.htm
Agree, would hope in the next couple weeks the marketing/info for the Endo diagnostics ramps up significantly, especially on the core resource sites.
So what are everyone's thoughts on Artguide's public reception? Let's say clinics realistically get the tests at the end of this month and patient results starting in December, do we think social media and news organizations are going to start blowing up over it?
Seems like it's destined to me to get natural publicity. Would seem like a perfect time to coordinate news releases of other major announcements.
Lol, his "source" note is satirical. All he posted is current info and related reasonable expectations.
If I was with/close to the company and found out someone was leaking information, I would probably start feeding them bad info.
I like Barry personally, but agree that all "sources" need to be taken with a varying grain of salt, and just focus on the fundamentals published.
How come everyone here seems to have a source? Lol, if it's a good source... they wouldn't be saying almost a damn thing.. or only to those who know how to keep there mouth shut... IMO.
Speaking of which, can someone please pass a source my way? Great, thanks, bye.
Agree... if anyone truly believes in the company, NOW is the time to buy while fear and perceived unknown is at peak. The volume we have been seeing lately is nothing but unnatural, and very indicative of a large
single accumulation party. If selling/shorting dries... the large buyers at that point would then start to buy into the ask... beat the wave!
Sure may go lower yet, but that likelihood and window is closing.
Just goes to show how disconnected you are from this if you believe my projections were ever that off. A jump to $10 could happen here within a matter of weeks at any time (depending on news release), just a guessing game of when that happens... still very close.
But you keep posting your proprietary charts too, and this time next year we'll assess who was closest.
The technical behind 1.05 is all about close price, not intraday.
Definitely weird, but there are multiple reasonable explanations... most of which would be best tackled by just getting back on the QX quickly rather than unwind via a statement. But I'm going to stop sharing my personal speculations and just watch, have not been fundamentally disappointed yet.
I'm also in the camp of thought that we are all lucky to be aware of this stock in this stage. If the company revealed all of the details that we speculate may be true to the public, or even marketed those that are available, this would be well past any price point we've seen so far. Too many looking for immediate returns and not comprehending what building blocks are necessary for long-term growth and stability. Even with myself... continually trying to keep my timing and expectations in line.
Alright, back to hibernation. Winter sucks.
That would be 68k shares. Are you sure you know how many you have? Lol
Good point, PRED could very well be the glue that holds all of our portfolios together over the long-term. Great allegory, cutesy.
No bailing out here, just patient...
The 228 million only accounts for management held shares and not the certificates, etc as Pelco mentioned. The 35M is by all means much closer to correct.
To be fair, the terms used are fairly straight forward for those in the industry. If you're an investor, it is probably worth creating a basis of knowledge to understand more about the competitive space and the significance of company's developments.
I'm still learning, and am still stupid! Lol
Be patient and watch the full day play out.
Nothing ludicrous about that price. Plenty of theorized deals that we might see that would justify that number very fast...
My updated/aggressive price targets FWIW... pure speculation based upon large continued buying for the next few months, Nasdaq (guessing around $5), and major announcements (pushing the $10-$15 range quickly).
$3: 11/2/19
$5: 11/9/19
$10: 12/5/19
$15: 12/31/19
$25: 3/1/20
$50: 12/1/20
$100: 12/1/21
I've been very wrong on timing before, but still not wavering in these price points being within reason.
Don't ignore all of the ding dongs though, otherwise you might miss the pizza boy.
"If you dress a king in sack clothes, he's still a king."
The "issue" for much of the investment community is price and exchange related. One of those concerns is bettered if not fixed for many...
PRED will never....
1. Have anyone of credibility join management.
2. Be audited.
3. Publish the 10-K.
4. Have SEC registration.
5. Have a partnership with any large medical company.
6. Get off the PINKs.
7. Uplist to the Nasdaq.
....
8. Be a $100 stock, you're out of your mind.
Both John Mackey and Adam Tischer are in Commercial Real Estate and appear to be doing very well in their respective markets (Boise ID / LA... very large). Johnny's LinkedIn profile is fairly old/well connected.. I see no reason to distrust the visit.
Thetalus was formed in June of this year. Nothing wrong with a newly formed fund for large investors to pile into, especially if they want to purchase a substantial amount of shares.
Thanks to the Eagle ID man that must have connected these two!
To each their own.
What's there to be upset about? The company has only gotten better, and the news only more substantial and revealing into the future.
The PPS right now means very little to me, it'll reflect where it needs to be eventually. I'm planning to be here for 5 years, not 5 weeks.
Happy investor here, only concern is the migraine I'm getting from your incessant whining.
I think the delay is not necessarily price but price volitility (as a few others have previously mentioned). Nasdaq has a major PR issue right now given SEC investigations, and will be wary to accept a company like PRED given price movement. The QX can both resolve the price issue as well as give the needed comfortability that institutions are hopping on to support.
I do agree that if it came down to price alone a R/S is not a bad solution, although another perception issue given historical use.
It's taken me 24 hours of reading/thinking, but I'll now be the first to admit that many of my initial reservations are wrong or were overstated. The QX has a lot of institutional support, and I would be all for it if it's what the company decides to do. Seems like a very good path for both the company and the Nasdaq to get price stability in the desired range before moving further. Would be very easy for the company to dispel any fear/perception.
Can't speak for Thomas, but personally I value seeing the levels of confidence from both field experts and those close to company dealings.
If QX or other strategy updates are in the cards, better to know about it now so we can get ahead of it before we're flooded with distortions.
It sounds like you've never held a pink before this. Your return potential is the highest it could ever be, but you have to understand that PPS doesnt necessarily follow normal logic.
Best thing to do is continually evaluate based upon the fundamentals where you believe the price should fall, and ignore the actual. Eventually the PPS should reconcile, we all just are hoping for sooner than later.
All the better for the investors. Hell of a risk/reward right now if anyone has the funds available.
We nor the company can ignore that perception of a move to the QX is a negative for many. Right, wrong, or indifferent… the perception is there. It’s like watching a 15 year old Freshman Lebron James go to JV instead of Varsity. Might be a good stepping stone, but many of the parents/friends will surely not see it that way at first (even if the coach thinks/explains it’s the best place for him to get recruiter visibility).
The market as a whole is centered upon what people think. If they move to the QX, the benefit would have to outweigh the perceptional issue. I for one still think it would be a waste of time/money as nothing is ever as cheap or easy as imagined.. there will be many board meetings, meetings with finance/legal, discussions with large shareholders, etc. and to me seems like a distraction when resources are currently prized. If they believe it’s needed to create stability and price support, great - do it.. but let’s not discredit the notion that there will be any detriment. We just need to be confident that the ROI walking into that risk is sound, otherwise there is a real threat of selling/distortion and negative price movement (if no immediate institutional support).
The only thing I’m personally tired of is explaining to family/friends how their money is still in good standing, and my gut just says this would make it more difficult. Understanding the perceived negative helps navigate through those conversations if the time comes.
Regardless of current opinion if a QX listing is in the works or not, nothing has been stated by the company. I'm still not a believer, but I've been wrong many times over.
Pelco noted it well, there are very viable reasons to do it, but you're also right that it would also come with the perception of not being able to meet Nasdaq for many. It's a very real factor, and the company and advisors would know this. If the time comes, there would be a statement and a very short benefit to offset.
Personally, I don't really care that much. If it happens I'll spend some time reading and undoubtedly come to same conclusion I've always been at with PRED.
I very much doubt we would see a QX listing, would be a waste of company time/resources in addition to being unnecessary IMO. I do not think getting the price to $3 for 5 days is an issue, nor do I think Nasdaq is forever away. Guess we will have to wait and see!
That's because you still think the company is targeting/needs general retail to bring it to $3.
Nothing about their recent releases tells me they're actively seeking additional investors, rather instilling confidence in their current.
I am of the opinion that the lack of marketing/PR is the best thing for us in the long-run. Frustrating, yes, but remember who the target investors truly are and what their current ownership % is. My belief is when the company and institutions are ready... the Nasdaq, PR, and the likes will be soon to follow.
There is a huge lens of skepticism in the biotech space since Theranos and PRED appears to be combatting the Theranos strategy line-by-line (science vs media focus, experience vs inexperience, deliver first then leverage potentials). PRED is actually acting like a multi-billion dollar company with what/when they've released. Too many people are used to the normal start-up behavior, which would be the absolute wrong tact for the long-term.
There is also no one that cares more about the stock price than management. Brad alone hold 40M shares, and dont kid yourself if you think they won't make sure the most advised route is followed.
Current price has little to no bearing given current manipulation and you and I know that. If you're an investor, these fluctuations dont matter, but if you're a trader they do (over-generalized obviously).
Being down does not make anyone wrong either, nor is anything black/white. Were people wrong to hold $NOW, $AAPL, etc in their early dips? Yes and no... short-term vs long-term.
PRED's potential is yet to be truly publicized (to even us here), but my bet is staked on that changing very soon.
PPS can/does follow potential though... depends on the developmental stage of the company. As companies shift from a primarily top-line growth focus to bottom-line, the PPS likewise shifts from potential to earnings.
What is typically done by analysts is just a calculation of PPS based upon forecast of future growth multiplied by a potential/risk factor.
PRED will be trading at much higher levels very soon, well before earnings reflect.
I'm just sad I'm tapped out of funds.
Remember that picture with Citic in the background? Clever, Thomas.